EventsWednesday, June 20 - Saturday, June 23, 2018
Drug Development Workshop
By application only. Deadline March 21.
A special opportunity for biomedical trainees (grad students, postdocs, and clinical fellows; within 2y of completing this phase of training) to participate in a unique drug development workshop to learn about critical questions that are addressed at each stage of the drug development process (from concept to approval). Participants will be exposed to a variety of roles/positions that support the pipeline, demystifying the process and exploring the skills needed for scientists and clinicians interested in biopharma or regulatory affairs careers.
This 3 day workshop, sponsored by Biogen, is held June 20-23, 2018 in Cambridge, MA, with an opening dinner on Wed. June 20th and closes with a luncheon on Sat.June 23rd afternoon. It will feature discussions and hands-on experience in drug development-related topics, including:
- The approval process for new drugs and biologics: Investigational New Drug (IND) to approval
- Generating a strong data package that includes pharmacology (preclinical, clinical), compound generation, safety (preclinical, clinical), biomarker, and clinical trial design and strategy
- Interacting with regulators
- How business development evaluates products of interest for licensing
- Differentiating between corporate development and corporate strategy
Selected participants will also have an opportunity for experiential learning on biopharma project teams and presentations to a mock governance body
Biogen will cover transportation (air, train, bus) and lodging and provide meals (breakfast, lunch, dinner) during the full workshop.
The workshop is design.ed for novices with familiarity of the drug development process (does not require previous experience working in biopharma or regulatory agencies). Nominees are selected based on the following criteria:
1) Interest in a biopharma or regulatory affairs career
2) Level of experience in drug development
3) Evidence of leadership
4) Those within 2 years of finishing this phase of their training
The goal of the workshop is to broadly disseminate findings and experiences; therefore, participants are expected to present on their experience upon return to Cornell.
Diversity in the pool of scientists and clinicians is particularly welcome. If interested, please include in your email to Susi Varvayanis (firstname.lastname@example.org):
1) your CV
2) a statement highlighting your interest in workshop, familiarity with drug development, including specific areas of interest, and outlining how the workshop will enhance your career aspirations
3) a suggestion as to how you would share the workshop experience with others
Preference is given to active BESTies. Priority given to earliest responders.
selected participants only